Treatment of Metastatic Neuroendocrine Tumors of the Thymus with Capecitabine and Temozolomide: A Case Series

Publisher： Karger

E-ISSN： 1423-0194|97|4|318-321

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.97, Iss.4, 2013-01, pp. : 318-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pancreatic Neuroendocrine Tumor Control: Durable Objective Response to Combination 177Lu-Octreotate-Capecitabine-Temozolomide Radiopeptide Chemotherapy

By  

Neuroendocrinology, Vol. 103, Iss. 5, 2015-06 ,pp. : 432-439

Karger

Access to resources Recommend Favorite

Survival and Prognostic Factor Analysis of 146 Metastatic Neuroendocrine Tumors of the Mid-Gut

By  

Neuroendocrinology, Vol. 89, Iss. 4, 2009-01 ,pp. : 471-476

Karger

Access to resources Recommend Favorite

Systematic Review of the Role of Targeted Therapy in Metastatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 104, Iss. 3, 2016-04 ,pp. : 209-222

Karger

Access to resources Recommend Favorite

Temozolomide: A Safe and Effective Treatment for Malignant Digestive Endocrine Tumors

By  

Neuroendocrinology, Vol. 90, Iss. 1, 2009-06 ,pp. : 67-72

Karger

Access to resources Recommend Favorite

Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy

By  

Neuroendocrinology, Vol. 97, Iss. 1, 2012-01 ,pp. : 74-85

Karger

Access to resources Recommend Favorite